5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.10▲ | 6.10▲ | 6.10▲ | 6.22▼ | 6.52▼ |
MA10 | 6.07▲ | 6.10▲ | 6.11▲ | 6.36▼ | 5.69▲ |
MA20 | 6.08▲ | 6.13▼ | 6.30▼ | 6.57▼ | 4.45▲ |
MA50 | 6.10▲ | 6.25▼ | 6.24▼ | 5.61▲ | 4.92▲ |
MA100 | 6.11▼ | 6.26▼ | 6.54▼ | 4.41▲ | 6.08▲ |
MA200 | 6.30▼ | 6.57▼ | 6.26▼ | 4.54▲ | 8.50▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.003▲ | -0.018▼ | -0.139▼ | 0.331▲ |
RSI | 54.849▲ | 44.610▼ | 44.458▼ | 49.252▼ | 58.596▲ |
STOCH | 87.608▲ | 41.863 | 26.123 | 32.032 | 80.512▲ |
WILL %R | -9.091▲ | -58.333 | -84.962▼ | -77.778▼ | -25.403 |
CCI | 106.667▲ | -11.625 | -57.165 | -90.958 | 75.211 |
RSI | $SLDB RSI(14) Crossed Below 50 | Set Alert |
Tuesday, August 12, 2025 01:20 PM
Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase ...
|
Tuesday, August 12, 2025 12:33 PM
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
|
Friday, August 01, 2025 08:34 AM
CHARLESTOWN, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company"), a life sciences company developing precision genetic medicines for neuromuscular and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 6.17 | 6.255 | 6.02 | 6.11 | 886,113 |
14/08/25 | 6.70 | 6.75 | 6.09 | 6.17 | 1,333,404 |
13/08/25 | 6.04 | 6.8075 | 5.87 | 6.68 | 1,449,514 |
12/08/25 | 6.15 | 6.3088 | 6.005 | 6.04 | 1,667,298 |
11/08/25 | 6.25 | 6.31 | 5.75 | 6.08 | 983,746 |
08/08/25 | 6.21 | 6.53 | 6.20 | 6.29 | 1,125,777 |
07/08/25 | 6.485 | 6.54 | 6.09 | 6.19 | 1,223,777 |
06/08/25 | 6.63 | 6.64 | 6.3582 | 6.51 | 1,109,736 |
05/08/25 | 6.83 | 6.91 | 6.59 | 6.70 | 708,515 |
04/08/25 | 6.85 | 7.0407 | 6.5401 | 6.82 | 1,126,899 |
|
|
||||
|
|
||||
|
|